Medivir Ab

Janssen R&d Ireland

Tibotec Pharmaceuticals Ltd.

Carl Erik Daniel Jönsson

Bengt Bertil Samuelsson

Åsa Annica Kristina Rosenquist

Pierre Jean-Marie Bernard Raboisson

Kenneth Simmen

Karl Magnus Nilsson

Dmitry Antonov

Susana Ayesa Alvarez

David Craig McGowan

Herman Augustinus De Kock

Hans Kristian Wallberg

David Craig Mc Gowan

Anna Karin Gertrud Linnea Belfrage

Lourdes Salvador Odén

Björn Olof Classon

Bjorn Olaf Classon

Herman Agustinus De Kock

Karl Magnus Milsson

Susana Ayesa Alverez

Kenneth Alan Simmen

ÅSa Annica Kristina Rosenquist

Inhibitors of HCV replication of formula (I) and the N-oxides, salts, or stereoisomers thereof, wherein the dashed line, X, R, R, R, R, R, R, and Rhave defined meanings; the preparation thereof; compositions containing compounds of formula (I), including bioavailable combinations with ritonavir; and the pharmaceutical uses thereof.

Macrocyclic inhibitors of hepatitis C virus

Compounds of the formula I: including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.

HCV inhibiting macrocyclic phenylcarbamates

Inhibitors of HCV replication of formula (I) and the N-oxides, salts, or stereoisomers thereof, wherein

Growing community of inventors

Huddinge, Sweden

Carl Erik Daniel Jönsson